AR117589A1 - SPLIT-DRUG MODULATOR ANTIBODY CONJUGATES AND METHODS OF USE - Google Patents
SPLIT-DRUG MODULATOR ANTIBODY CONJUGATES AND METHODS OF USEInfo
- Publication number
- AR117589A1 AR117589A1 ARP190101481A ARP190101481A AR117589A1 AR 117589 A1 AR117589 A1 AR 117589A1 AR P190101481 A ARP190101481 A AR P190101481A AR P190101481 A ARP190101481 A AR P190101481A AR 117589 A1 AR117589 A1 AR 117589A1
- Authority
- AR
- Argentina
- Prior art keywords
- drug
- methods
- split
- antibody conjugates
- antibody
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
Se divulgan compuestos de enlazador-fármaco y conjugados anticuerpo-fármaco que se unen a blancos de oncología humana. Los compuestos de enlazador-fármaco y los conjugados anticuerpo-fármaco comprenden un resto farmacológico de modulador de empalme. La divulgación además se refiere a métodos y composiciones para usar en el tratamiento de trastornos neoplásicos administrando los conjugados anticuerpo-fármaco proporcionados en la presente.Linker-drug compounds and antibody-drug conjugates that bind to human oncology targets are disclosed. Linker-drug compounds and antibody-drug conjugates comprise a splice modulator drug moiety. The disclosure further relates to methods and compositions for use in treating neoplastic disorders by administering the antibody-drug conjugates provided herein.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862679631P | 2018-06-01 | 2018-06-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR117589A1 true AR117589A1 (en) | 2021-08-18 |
Family
ID=77568232
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190101481A AR117589A1 (en) | 2018-06-01 | 2019-05-31 | SPLIT-DRUG MODULATOR ANTIBODY CONJUGATES AND METHODS OF USE |
| ARP210103144A AR124059A2 (en) | 2018-06-01 | 2021-11-12 | SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210103144A AR124059A2 (en) | 2018-06-01 | 2021-11-12 | SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE |
Country Status (1)
| Country | Link |
|---|---|
| AR (2) | AR117589A1 (en) |
-
2019
- 2019-05-31 AR ARP190101481A patent/AR117589A1/en unknown
-
2021
- 2021-11-12 AR ARP210103144A patent/AR124059A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR124059A2 (en) | 2023-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2020016137A2 (en) | Splicing Modulator Antibody-Drug Conjugates and Methods of Use | |
| CL2021001534A1 (en) | Herboxydiene of antibody-drug conjugates and methods of use. | |
| CL2021000048A1 (en) | Eribulin-Based Drug-Antibody Conjugates and Methods for Their Use (Divisional Application 2456-2018) | |
| CR20160271A (en) | PEPTIDOMETIC COMPOUNDS AND THEIR ANTIBODY-DRUG CONJUGATES | |
| CO2020014009A2 (en) | Mcl-1 inhibitors | |
| AR122270A1 (en) | MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND THEIR METHODS OF USE | |
| UY39188A (en) | IMIDAZOPYRIDAZINES AS IL-17 MODULATORS | |
| ECSP21089206A (en) | ANTIBODY AND DRUG CONJUGATES | |
| CR20190296A (en) | Antibody drug conjugates for ablating hematopoietic stem cells | |
| CO2022003703A2 (en) | therapeutic conjugates | |
| BR112021017616A2 (en) | Anti-Her2-Pyrrolobenzodiazepine Antibody Derivative Conjugate | |
| AR129413A2 (en) | SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | |
| ECSP20082970A (en) | ANTI-SEZ6 DRUG AND ANTIBODY CONJUGATES AND METHODS OF USE | |
| AR117589A1 (en) | SPLIT-DRUG MODULATOR ANTIBODY CONJUGATES AND METHODS OF USE | |
| AR117686A1 (en) | HERBOXIDIENE SPLIT MODULATOR OF ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | |
| UY38265A (en) | DRUG ANTIBODY CONJUGATES FOR ABLATION OF HEMATOPOIETIC STEM CELLS | |
| AR129382A1 (en) | BCL-XL AND MET INHIBITORS ANTIBODY-DRUG CONJUGATES AND THEIR METHODS OF USE | |
| EA202092951A1 (en) | ANTIBODY AND DRUG CONJUGATES AS A SPLICING MODULATOR AND METHODS OF THEIR APPLICATION | |
| CO2023008051A2 (en) | Anti-cd48 antibodies, antibody-drug conjugates, and uses thereof | |
| AR117405A1 (en) | USE OF ANTIBODY-DRUG CONJUGATES INCLUDING TUBULIN-ALTERING AGENTS TO TREAT SOLID TUMORS | |
| AR117446A1 (en) | ANTI-PMEL17 ANTIBODIES AND CONJUGATES THEREOF | |
| AR098781A1 (en) | PEPTIDOMIMETIC COMPOUNDS AND ANTIBODY-DRUG CONJUGATES OF THE SAME | |
| AR114448A1 (en) | ANTI-HER2 DRUG-BIPARATOPIC ANTIBODY CONJUGATES AND METHODS OF USE |